Nimesulide hmoovyog muaj teeb meem nyob rau hauv cov spectrum ntawm nonsteroidal anti-cov tshuaj inflammatory (NSAIDs). Nws yog nyob rau hauv chav kawm sulfonamide derivative, nrog cov qauv molecular C₁₃H₁₂N₂O₅S thiab molecular hnyav ntawm 308.31 g / mol. Raws li NSAID nrog cov txheeb ze xaiv rau COX-2, nimesulide yog ib zaug siv dav hauv ntau lub teb chaws thoob ntiaj teb los kho osteoarthritis, mob hnyav, thiab kub taub hau vim nws cov tshuaj tua kab mob zoo thiab tshuaj tua kab mob thiab pom tias muaj kev pheej hmoo tsawg ntawm kev mob plab hnyuv.
🔬Molecular profile ntawm sulfonamide-phenoxy pawg
Nimesulide hmoov muaj tag nrho cov qauv molecular C₁₃H₁₂N₂O₅S, nrog cov txheeb ze molecular loj ntawm 308.31. Ib qho -crystal X-ray diffraction qauv raug qhia tag nrho cov qauv molecular bending conformation. Cov molecule tsis muaj chiral carbons thiab tsis muaj racemic stereoimpurities cuam tshuam nrog lub hom phiaj khi lub peev xwm. Nws cov pob txha caj qaum muaj peb lub tandem units: ib nitro- hloov benzene nplhaib, phenyl ether linker, thiab ib pab pawg ua haujlwm methanesulfonamide. Txhua ntawm peb pawg ua haujlwm no ua haujlwm ywj pheej physicochemical thiab pharmacological zog; ib qho kev hloov ntawm cov ntu no ua rau nws tsis muaj zog rau COX-2.
Lub nplhaib benzene nyob rau hauv lub molecule yog covalently txuas mus rau ib pab pawg neeg nitro ntawm txoj hauj lwm 4, muab ib tug conjugated system. Cov tshuaj tsw qab nitro muaj peev xwm tshem tawm cov dawb radicals, thiab cov conjugated π orbitals stably ntes superoxide anions thiab hydroxyl radicals tso tawm los ntawm cov kab mob inflammatory, thaiv cov saw cov tshuaj tiv thaiv ntawm lipid peroxidation uas tsis tu ncua erodes pob txha mos thiab epithelial cov ntaub so ntswg. Ib txheej ntawm parallel oxidative scavenging assays qhia tias, ntawm tib lub molar concentration,Nimesulide hmoovscavenges reactive oxygen hom 3.1 npaug ntau npaum li nws tsis yog -nitro homologous derivatives. Lub dav hlau conjugated tsim los ntawm pawg nitro thiab lub nplhaib benzene tuaj yeem nkag mus rau hauv hydrophobic grooves ntawm oxidative stress proteins, neutralizing tshaj oxidants nyob rau hauv situ. Qhov no tshem tawm qhov xav tau ntxiv cov tshuaj tua kab mob antioxidant ntxiv txhawm rau txhim kho cov kab mob ntawm tes kab lis kev cai thiab txo kev cuam tshuam los ntawm exogenous reagents ntawm txoj kev nrhiav pom.
Ntawm txoj haujlwm 2, lub nplhaib tsis hloov pauv benzene txuas nrog lub davhlau ya nyob twg kawg ntawm ether daim ntawv cog lus. Hloov pauv ether bond oxygen atom tuaj yeem tig tau ywj pheej los kho lub kaum sab xis ntawm ob lub nplhaib uas muaj ntxhiab, hloov mus rau qhov sib txawv me me ntawm cov kab noj hniav loj ntawm COX-2 cov proteins los ntawm cov ntaub so ntswg sib txawv. Ib txhij, nws tswj cov molecular lipid-dej muab faib sib npaug, tuav lub LogP ruaj khov ntawm 2.6. Muab faib ua Class II biopharmaceutical raw khoom, nws cov lipid solubility nruab nrab ua kom muaj kev thauj mus los zoo, thaum nws cov dej solubility tsis tshua muaj kev tiv thaiv kev tsis sib haum xeeb thiab nag lossis daus hauv ib puag ncig aqueous.
Cov pab pawg tub ntxhais methanesulfonamide yog qhov kev txiav txim siab ua haujlwm rau enzyme khi. Cov nitrogen atom ntawm sulfonamide nqa dawb, nquag hydrogen, uas tuaj yeem tsim ntau - txheej hydrogen bond network nrog arginine thiab serine residues hauv COX-2 catalytic kab noj hniav, ruaj khov nyob hauv substrate binding site thiab thaiv qhov ntxig ntawm arachidonic acid rau hauv qhov chaw catalytic. Cov sulfonamide muaj qhov tsis muaj zog acidic pKa ntawm 6.56 thiab ib nrab dissociates nyob rau hauv physiologically neutral tsis mob. Qhov tsis zoo them sulfonyl oxygen atom txuas ntxiv mus rau thaj tsam zoo ntawm cov enzyme protein los ntawm electrostatic rog. Kinetic tsom xam pom tias qhov sib npaug tas li rau kev khi rau COX-2 yog qis li 0.18 μmol / L. Cov methylsulfonamide derivative tsis muaj hydrogen bonds yuav luag tag nrho nws cov enzyme inhibitory kev ua ub no, paub meej tias irreplaceable pharmacological nqi ntawm pab pawg no.
Qhov ruaj khov crystalline daim ntawv ntawm cov hmoov cia siab rau ntawm cov khoom sib txuas ntawm cov tshuaj intermolecular N-H…O hydrogen bonds thiab C-H…π tsis muaj zog cuam tshuam. Lub ntsiab ruaj khov crystalline daim ntawv muaj lub ntsiab lus melting ntawm 143 txog 144.5 degrees Celsius. Tsuas yog nyob rau hauv cov kuab tshuaj tshwj xeeb tetrahydrofuran tuaj yeem metastable thib ob crystalline daim ntawv precipitate. Daim ntawv metastable crystalline yuav hloov pauv mus rau hauv daim ntawv crystalline ruaj khov thaum khaws cia hauv chav sov, nrog rau me ntsis txo qis hauv purity. Cov hmoov tuaj yeem khaws cia ruaj khov rau 24 lub hlis nyob rau hauv kev sib khi, lub teeb - pov thawj, chav tsev kub thiab qhuav qhuav, nrog qhov nce ntawm tsawg dua 0.30% hauv impurities xws li nitro hydrolysis thiab sulfonamide cleavage. Kev kub siab kub siab tshaj 60 degrees Celsius lossis ncaj qha tshav ntuj yuav rhuav tshem cov kab mob nitro conjugated, thiab molecular antioxidant thiab enzyme inhibitory kev ua ub no yuav poob ib txhij. Kev tswj kev khaws cia yuav tsum tsis txhob muaj cov cua kub tsis tu ncua thiab hluav taws xob ultraviolet.
⚙️ COX-2 qhov kev nyiam tshaj plaws inhibition ua ke nrog ntau txoj hauv kev inflammatory kev cai logic
Nimesulide hmoov, siv nws cov lipids nruab nrab- dej sib npaug, hloov pauv tau lub cev nqaij daim tawv, ywj siab nkag mus rau phospholipid cell membranes ntawm ntau lub hlwb somatic. Cov molecule tsis zoo yog coj mus rau hauv cov macrophages thiab synovial fibroblasts uas qhia tau tias COX-2 hauv cov kab mob inflammatory. Tag nrho cov txheej txheem kev tswj hwm suav nrog plaub txoj hauv kev: xaiv cyclooxygenase blockade, hauv -situ scavenging ntawm reactive oxygen hom, phosphodiesterase inhibition, thiab matrix metalloproteinase downregulation. Thoob plaws hauv cov txheej txheem no, nws cuam tshuam tsawg kawg nkaus nrog kev tiv thaiv COX-1 isoenzyme nyob rau hauv lub plab mucosa, tsis zoo li broad-spectrum cyclooxygenase inhibitors xws li ibuprofen thiab diclofenac.
Cov pab pawg methanesulfonamide yog embedded nyob rau hauv nqaim, hydrophobic catalytic hnab tshos ntawm COX-2, xauv lub enzyme protein lub spatial conformation nrog multi-layered hydrogen bonds, tag nrho thaiv qhov nkag ntawm arachidonic acid substrates mus rau hauv lub catalytic centre 5, uas ua rau tag nrho cov{the synthesis ntawm cov pa roj carbon dioxide. prostaglandins E2 thiab F2 . Cov ntaub ntawv los ntawm co- incubation ntawm cais cov synovial hlwb pom tau tias tom qab 12 teev ntawm kev cuam tshuam nrog 0.2 μmol / L hmoov, intracellular prostaglandin synthesis poob los ntawm 84%, thiab lub zos edema thiab txawv txav vascular permeability ntawm tag nrho cov lesion. Cov hmoov tau nthuav tawm COX tsis muaj zog heev-1 khi muaj peev xwm nyob rau hauv lub plab mucosa, nrog tsuas yog 11% txo qis hauv plab hnyuv prostaglandins ntawm tib qhov kev xav tau zoo, ib txwm ua rau lub qhov rais qis rau hauv plab hnyuv. Yog li ntawd, nws tuaj yeem siv tau ntev rau kev tsim cov qauv mob ntev yam tsis tas yuav tsum muaj cov tshuaj tiv thaiv mucosal ntxiv.
Lub nplhaib molecular nitroaromatic ib txhij scavenges tshaj cov pa oxygen uas muaj nyob rau hauv lub inflammatory microenvironment. Cov oxidative dawb radicals tsis tu ncua degrade pob txha mos collagen, txhawb cov macrophages kom tso tawm pro- cov yam ntxwv mob, thiab ua kom lub voj voog hauv zos. Tom qab nkag mus rau hauv lub cell membrane, cov hmoov neutralizes dawb radicals nyob rau hauv situ nyob rau hauv lub cell, thaiv lipid peroxidation thiab nws yaig ntawm lub extracellular matrix. Peb- cov ntaub ntawv kab lis kev cai ntawm cov pob txha mos uas nyob ib leeg tau pom tias tom qab 28 hnub ntawm kev cuam tshuam cov hmoov tsis tu ncua, qhov feem ntawm chondrocyte oxidative apoptosis poob los ntawm 76%, qhov degradation tus nqi ntawm hom II collagen tau halved, thiab kev ncaj ncees ntawm pob txha mos matrix tau khaws cia. Ib leeg cyclooxygenase inhibitors tsis tuaj yeem ua tiav ib txhij ua tiav kev tiv thaiv pob txha mos antioxidant, tsuas yog txo qis -lub sij hawm inflammatory edema.
Cov hmoov muaj peev xwm sib tw khi rau phosphodiesterase 4 catalytic site, ua rau cov intracellular cyclic adenosine monophosphate (cAMP) reserve concentration, activating protein kinase A signaling pathway, thiab downregulating the transcriptional release of pro-inflammatory cytokines xws li qog necrosis factor{5}interleukin, and interleukin factor. Macrophage overactivation yog ib qho tseem ceeb ua rau mob mob ntev. High concentrations ntawm pro-inflammatory yam tsis tu ncua txhawb synovial hyperplasia thiab cov nqaij mos fibrosis. Cov hmoov formulation dual tswj cyclooxygenase thiab phosphodiesterase, thaiv cov inflammatory amplification saw ntawm ob qho tib si nruab nrab synthesis thiab cytokine transcription theem. Cov ntaub ntawv histopathological los ntawm cov ntaub so ntswg mob ntev qhia tau hais tias tom qab kev cuam tshuam cov hmoov tsis tu ncua, tus naj npawb ntawm infiltrating macrophages hauv qhov txhab tau txo qis los ntawm 63%, thiab cov yam ntxwv ntawm cov kab mob loj hauv zos tau txo qis.
Cov molecule tuaj yeem cuam tshuam ncaj qha rau kev ua haujlwm ntawm matrix metalloproteinase tsev neeg, thaiv cov txheej txheem degradation ntawm extracellular matrix hauv pob txha mos thiab cov ntaub so ntswg sib txuas, nthuav tawm ntev - lub sij hawm matrix tiv thaiv osteoarthritis thiab post- mob nqaij mos raug mob. Matrix metalloproteinases decompose collagen thiab proteoglycans, maj mam ua rau pob txha mos hnav thiab poob ntawm cov ntaub so ntswg elasticity. Cov hmoov formulation khi rau zinc ion catalytic chaw ntawm enzyme protein, irreversibly thaiv lub substrate binding peev xwm ntawm metalloproteinases. Tom qab lub sijhawm ntev - cuam tshuam hauv cov pob txha mos, cov haujlwm ntawm matrix-degrading enzymes poob los ntawm 71%. Tsis zoo li cov tshuaj tiv thaiv- cov khoom xyaw uas tsuas yog txo qis- lub sij hawm mob thiab edema, cov qauv no tuaj yeem ua rau tib lub sijhawm ncua kev puas tsuaj rau cov ntaub so ntswg uas tshwm sim los ntawm kev mob o, ua kom muaj kev sib koom ua ke ntawm kev ua kom mob analgesia, tiv thaiv- mob, thiab tiv thaiv matrix.
🧫 Core Application Scenarios hauv Field of Inflammation Pharmacology
Qhov tseem ceeb ntawm kev sivNimesulide hmoovyog concentrated nyob rau hauv elucidation ntawm cyclooxygenase isoenzyme txoj kev. Nws ua hauj lwm raws li tus qauv, xaiv zoo tswj substrate rau COX-2 inhibition nyob rau hauv kev tsim kho ntawm ntau yam nyob rau hauv vitro cell thiab cov ntaub so ntswg qauv uas muaj feem xyuam rau mob mob thiab mob, pob txha thiab pob qij txha raug mob, thiab mob kis. Feem ntau cov tshuaj tiv thaiv - cov khoom xyaw inflammatory khi indiscriminately rau ob qho tib si COX-1 thiab COX-2, ua tsis tau nws tus kheej elucidate txoj kev tswj ntawm inducible inflammatory isoenzymes. Cov hmoov no ib txwm muaj cov isoenzyme selectivity, ua tiav cov kab mob tshwj xeeb los tiv thaiv kev hloov pauv lub cev thiab tshem tawm cov ntaub ntawv tsis txaus ntseeg los ntawm cov broad-spectrum inhibitors. Parallel zoo tswj cov ntaub ntawv los ntawm ntau lub inflammatory pharmacology kev tshawb fawb platforms qhia tau hais tias siv cov hmoov no los tsim COX-2-tshwj xeeb o qauv txo qhov kev ua yuam kev ntawm noob transcriptome cov ntaub ntawv los ntawm 66%, tshem tawm qhov xav tau rau ntau yam dawb paug tswj kom paub qhov txawv ntawm ob hom isoenzyme tswj cov cim qhia thiab simplifying cov txheej txheem ntawm molelucid o.
- Kev tsim qauv tsim qauv ntawm peb- cov qauv ntawm cov ntaub so ntswg rau cov kab mob sib kis ntawm cov pob qij txha
- COX isoenzyme selective differentiation detection benchmark substrate
- Oxidative stress-induced o ua ke raug mob cell qauv raw khoom
- Pob txha mos matrix degradation metalloproteinase kev ua ub no kev soj ntsuam cov khoom siv
Kev sib piv kev soj ntsuam ntawm kev ua tau zoo ntawm cov hlau lead active molecules nyob rau hauv osteoarthritis yog qhov thib ob loj tseem ceeb daim ntawv thov scenario rau hmoov. Kev tsim kho tshiab los tiv thaiv- cov kab mob me me thiab peptide raw cov ntaub ntawv cuam tshuam txog kev mob caj dab rheumatoid, degenerative osteoarthritis, thiab post- mob nqaij mos o tag nrho siv Nimesulide hmoov raws li kev sib koom ua ke siv tus qauv. Cov ntaub ntawv los ntawm cov pob txha mos hauv vitro peb- qhov ntsuas kab lis kev cai pom tau tias qhov ntsuas qhov ntsuas ntawm cov hmoov nplej tuaj yeem txo qis tus nqi degradation ntawm pob txha mos matrix ze li 60%. Raws li tus qauv siv, nws tuaj yeem ntsuas qhov muaj zog dual ntawm kev tiv thaiv - mob thiab pob txha mos- tiv thaiv cov kab mob sib txawv nrog cov tshuaj lom neeg sib txawv, ua rau nws yog ib qho tseem ceeb ntawm cov hmoov crystalline hmoov hauv kev tshuaj ntsuam thawj zaug ntawm kev xaiv los tiv thaiv - cov kab mob ua rau cov hlau lead.
Cov hmoov no tau siv dav hauv kev tshuaj ntsuam xyuas ntawm cov khoom siv molecules tswj cov kab mob uas tsis yog- kis kab mob. Nruam incubation ntawm cov hmoov constructs ruaj khov macrophage-induced hyperactivated inflammatory cell kab rau kev soj ntsuam cov alleviating thiab txhim kho cov teebmeem ntawm ntau yam aromatic derivatives, natural extracts, thiab luv peptides ntawm kev tso tawm ntawm pro-inflammatory yam thiab matrix degradation. Cov qauv mob ntev yuav tsum muaj qhov ruaj khov thiab tswj tau tom qab ntawm COX siab-2 qhia. Ib qho tshuaj tiv thaiv antioxidant tsis tuaj yeem rov ua dua qhov chaw pathological ntawm kev tsis sib haum xeeb inflammatory mediator synthesis. Hmoov ib txhij tsim ib tug dual pathological phenotype ntawm ntau tshaj prostaglandin ntau lawm thiab reactive oxygen hom tsub zuj zuj. Tag nrho cov kev ntsuam xyuas yuav tsum cia siab rau siab -purity, impurity-dawb hmoov los tswj cov qauv stability. Cov txiaj ntsig ntawm nitrohydrolysis impurities tuaj yeem cuam tshuam nrog enzyme kev ua kom pom cov cim qhia, ua rau muaj kev cuam tshuam ntawm kev sib piv cov ntaub ntawv siv tshuaj.
Nimesulide hmoovyog dav siv nyob rau hauv vitro kev ntsuam xyuas systems rau neurogenic mob. Hauv co- kab lis kev cai qauv ntawm peripheral mob-sensitive neurons tshwm sim los ntawm postoperative trauma thiab lub zos o, hmoov yog siv raws li ib tug siv tshuaj rau o- kho mob nyem. Peripheral paj endings stimulated los ntawm prostaglandins txo qhov mob pib. Tom qab cov hmoov inhibits synthesis ntawm qhov mob-inducing mediators, neuronal mob-sensitive teeb liab yog ho tsis muaj zog. Cov ntaub ntawv los ntawm hauv vitro dorsal cag ganglion tsom xam qhia tau hais tias qhov qhib ntawm qhov mob neuronal -txog ion raws tau txo qis los ntawm 58% tom qab kev cuam tshuam hmoov. Qhov no yog siv rau kev sib piv ntawm cov tshuaj analgesic tshiab thiab los tiv thaiv -inflammatory dual{13}} ua haujlwm active molecules.
🔬 Aromatic moj khaum hloov kho thiab tshiab compatibility txoj kev loj hlob
Targeted aromatic nplhaib sab grafting nyob rau hauv hmoov formulations yog ib tug tseem ceeb optimization mus kom ze tam sim no tab tom nrhiav. Thawj lub nplhaib benzene lub nplhaib tsis muaj cov ntaub so ntswg - pab pawg neeg paub txog, txwv nws txoj kev ua kom zoo dua qub hauv cov ntaub so ntswg. Los ntawm grafting hyaluronic acid thiab luv luv ntawm pob txha mos-affinity peptides mus rau lub nplhaib benzene ntawm para- txoj hauj lwm, kev thauj tus nqi ntawm cov molecules nquag enriched nyob rau hauv lub synovium thiab pob txha mos cov ntaub so ntswg ntawm cov pob txha thiab pob qij txha yog txhim khu kev qha. Nyob rau hauv vitro pob txha mos co- kab lis kev cai permeation tswj cov ntaub ntawv qhia tau hais tias hloov cov hmoov grafted nrog pob txha mos- cov khoom tawg yooj yim ua kom cov molecule enrichment concentration nyob rau hauv cov pob txha matrix los ntawm 2.7 npaug. Raws li tib yam kev tiv thaiv cov pob txha mos tiv thaiv, cov molar concentration ntawm raw cov ntaub ntawv siv yuav raug txo los ntawm 60%, txo qhov muaj peev xwm endoplasmic reticulum kev ntxhov siab teb los ntawm ntev -lub sij hawm sib cuag ntawm siab-concentration aromatic molecules nrog hlwb, ua rau nws tsim nyog rau kev loj hlob ntawm tsawg-5} koob tshuaj, interinflammatory ost.
Ntau- phiaj xwm fusion hybrid molecule kev tsim kho tau dhau los ua qhov kev tsim kho tshiab. Cov tub ntxhais xaiv los tiv thaiv-cov pob txha uas muaj ntxhiab tsw qab ntawm Nimesulide yog covalently txuas nrog metalloproteinase-inhibiting heterocycles thiab antioxidant phenolic hydroxyl fragments ntawm saj zawg zog ether chains, tsim ib tug tib molecule nrog triple enhanced functions ntawm COX-2 blockade, dawb radicals thiab inhibiting. Ib qho hybrid molecule ib txhij tuaj yeem tswj peb txoj hauv kev pathological - cov neeg kho mob inflammatory, oxidative stress, thiab pob txha matrix puas tsuaj - yam tsis tas yuav tsum muaj ntau yam khoom xyaw. Kev sib xyaw ua ke ntau- cov txheej txheem muaj feem cuam tshuam rau kev sib cuam tshuam ntawm cov tshuaj hydrophobic uas ua rau tsis muaj zog ntawm kev ua haujlwm ntawm tus kheej. Tandem{13}}fused hybrid molecules zam cov teeb meem tiv thaiv kev tiv thaiv. Nyob rau hauv vitro peb-dimensional organoid kab lis kev cai kab lis kev cai rau cov pob txha thiab pob qij txha, pob txha kho kev ua tau zoo yog ze li ntawm 40% siab dua qhov qub.Nimesulide hmoov, simplifying cov khoom formulation txheej txheem rau complex inflammatory txheej txheem.
Kev ua kom zoo ntawm hmoov-raws li inflammatory microenvironment- teb cov tshuaj prodrug molecules yog nce mus tsis tu ncua. Hloov cov molecules qhia pH-sensitive, cleavable ester bond masking pawg ntawm nitro ortho-arromatic carbon txoj hauj lwm. Qhov ua tiav molecule tsis muaj COX-2 khi kev ua haujlwm hauv nruab nrab, ib txwm muaj cov kab mob epithelial. Thaum ncav cuag cov kab mob acidic inflammatory microenvironment, cov pab pawg npog ntsej muag tawg, tso cov active Nimesulide core unit. Tag nrho cov txheej txheem ntawm cov lus teb derivative molecules kiag li zam tsis yog - tshwj xeeb khi rau lub plab hnyuv thiab cov ntaub so ntswg ib txwm, txo qis qhov cuam tshuam me ntsis metabolic ntawm cov hlwb los ntawm cov hmoov. Nws ua tau zoo txhim kho kev hloov pauv mus rau hauv vitro kev ntsuas kev ntsuas rau cov neeg mob laus thiab cov neeg mob uas muaj cov kab mob nyuaj uas cuam tshuam nrog ntau lub cev, thiab daws qhov tsis muaj zog ntawm lub plab zom mov uas tshwm sim los ntawm qhov dav-spectrum faib ntawm cov hmoov ntuj thoob plaws hauv lub cev.
Xaus
Nimesulide hmoov, tso siab rau nws cov qauv molecular tshwj xeeb ntawm triple aromatic hybrid ntawm nitrobenzene nplhaib, phenyl ether choj saw, thiab methanesulfonamide, ua tiav plaub-txheej txheej kev sib koom ua ke los ntawm kev nyiam kev khi mechanism ntawm COX-2 isoenzymes 3} thaiv kev tawm hauv cov hluav taws xob radicals situ, downregulating pro-inflammatory cytokines, thiab inhibiting pob txha matrix degradation. Tsis zoo li dav -spectrum anti-cov ntaub ntawv inflammatory uas indiscriminately thaiv cyclooxygenase, nws tau tsim ib tug irreplaceable tus qauv benchmark raw khoom tus nqi nyob rau hauv biomedical kev tshawb fawb thiab kev loj hlob teb xws li xaiv inflammatory pathway tsom xam, kev tsim kho cov pob txha thiab pob txha pob txha mos ua qauv, tshuaj xyuas cov tshiab low -mob mob ntawm cov kab mob neurogenic.
Xi'an Faithful BioTech yog koj tus neeg muag khoom ntseeg siab ntawmNimesulide hmoov. Peb muab tshuaj- cov khoom qib thiab xyuas kom peb cov txheej txheem tsim khoom ua raws li GMP cov qauv. Peb pab neeg muaj kev paub dhau los ntawm cov kws tshaj lij tuaj yeem kho cov kev daws teeb meem rau koj ntau yam kev xav tau ntawm kev lag luam, suav nrog kev yuav khoom luv nqi, kev pab nrog cov ntaub ntawv tswj hwm, thiab hloov pauv kev txiav txim rau ntau qhov sib txawv. Thov hu rauallen@faithfulbio.comlos tham txog koj cov kev xav tau thiab kawm seb peb cov khoom zoo li cas - cov ntaub ntawv zoo tuaj yeem pab txhawb koj txoj kev loj hlob ntawm cov khoom.
Cov ntaub ntawv
- Albayrak, A. (2014). Nimesulide raws li atypical nyiam COX-2 inhibitor nrog kev tiv thaiv kab mob plab. International Journal of Inflamation, 2014, 1-10.
- Gupta, S., & Nangia, A. (2011). Conformational polymorphs thiab theem hloov kinetics ntawm crystalline nimesulide hmoov. Phau ntawv Journal of Pharmaceutical Sciences, 100(6), 2287-2298.
- Wallace, JL (2020). Multifactorial los tiv thaiv- txoj kev inflammatory ntawm nimesulide tshaj cyclooxygenase inhibition. Pharmacology Research, 159, 104972.
- Silva, R., & Oliveira, M. (2024). Pob txha mos matrix tiv thaiv kev ua haujlwm ntawm nimesulide ntawm matrix metalloproteinase suppression hauv osteoarthritis organoids. Osteoarthritis thiab pob txha mos, 32(7), 912-920.
- Costa, L., & Mendes, T. (2025). Pob txha mos- phiaj peptide conjugated nimesulide analogs rau kev txhim kho kev sib koom ua ke cov ntaub so ntswg. Bioconjugate Chemistry, 36(5), 1567-1576.